BRITISH COLUMBIA

Medical Marijuana Recall By Greenleaf Medicinals

04/22/2014 12:37 EDT | Updated 04/22/2014 12:37 EDT
Rod Rolle via Getty Images
SANTA BARBARA, CA - APRIL 6: Purple Kush, a medical marijuana developed by Trichome Technologies, lies on display at the HortiPharm on April 6, 2006 in Santa Barbara, California. The dispensary will hold an open house for delegates at the 4th National Clinical Conference on Cannabis Therapeutics in Santa Barbara, California from April 6-8. (Photo by Rod Rolle/Getty Images)

In what's believed to be the first-ever marijuana recall in Canada, a B.C. company is asking its clients to avoid using a batch of Purple Kush.

Greenleaf Medicinals of Nanaimo is voluntarily recalling Batch PK-10-20-13, which was produced for medical purposes.

“The recall is due to issues with the company’s production practices which were identified during an inspection by Health Canada and may impact the product," said a news release posted on the agency's website on Friday.

Greenleaf said it's working with other licensed producers to find a marijuana supply for the impacted clients.

Customers were being asked to stop using pot from this shipment, but anyone who already used it is not in danger.

"Producers of marijuana for medical purposes are subject to compliance and enforcement measures similar to those in place for other producers of controlled substances. They must meet strict security, control and reporting requirements, and they are regularly inspected," said Health Canada.

The federal agency oversees the medical marijuana industry in Canada, while recreational pot use remains illegal. Health Canada has come under scrutiny for how it's handled the recent transition from private medical marijuana grow-ops to a system of licensed corporate producers.

Like this article? Follow our Facebook page

Or follow us on Twitter

Also on HuffPost

Top 50 Most Influential Marijuana Users